What IDEXX BioAnalytics does

IDEXX BioAnalytics is a wholly-owned business unit of IDEXX Laboratories, Inc. (NASDAQ: IDXX) that operates a network of specialty research testing laboratories serving more than 4,000 organizations worldwide. The company provides customized laboratory testing services spanning three core practice areas: Health Monitoring (sentinel health monitoring, environmental health monitoring via REPLACE and EDx panels, quarantine testing, and species-specific panels for rodents and aquatics); Biologics & Cell Health (cell line authentication under the CellCheck™ brand, IMPACT™ and h-IMPACT™ pathogen testing panels, ConfirmPDX tumor model confirmation, sterility, endotoxin, and mycoplasma testing); and Preclinical Testing (clinical pathology, histopathology with HALO Digital Image Analysis, bioanalysis, and veterinary clinical trials). It addresses a horizontal mix of biopharmaceutical companies, contract research organizations, academic and research institutions, and government entities, with applications organized by therapeutic area (oncology, cardiovascular, inflammatory, neurodegenerative, metabolic, wound healing) and modality (antibody therapeutics, cell & gene therapy, vaccines, medical devices).

Underlying technology is conventional specialty-lab instrumentation rather than a proprietary AI platform. Core methods include Real-Time PCR, serology, microbiology, histopathology with digital image analysis, and small-molecule bioanalysis; the CellCheck™, IMPACT™, h-IMPACT™, REPLACE, and EDx panels represent proprietary assay configurations supported by IDEXX's veterinary diagnostics heritage. Lab footprint comprises four US sites (Westbrook ME, Columbia MO, West Sacramento CA, North Grafton MA) and a European headquarters lab in Kornwestheim, Germany, operated through the legal entity IDEXX GmbH.

Commercial model is project-based laboratory services revenue priced per quote rather than per test list, with multi-year contracts in place and ordering executed through a self-serve client portal (secure.idexxradil.com) augmented by a direct enterprise sales team and a phone-based client support desk (1-800-669-0825). Go-to-market combines enterprise field sales for large accounts with content marketing and on-demand webinars targeting researchers; regional sites cover Europe, South America, Middle East, Asia, and Oceania even where dedicated labs do not exist. As a subsidiary division inside a publicly traded S&P 500 parent, IDEXX BioAnalytics does not have separate funding events and reports within IDEXX's consolidated financials.

Name

IDEXX BioAnalytics

Legal name

IDEXX Laboratories, Inc.

Website

https://idexxbioanalytics.com

Company type

Public

Operating status

Operating

Headcount range

251–500 employees

Short description

IDEXX BioAnalytics is a wholly-owned subsidiary division of IDEXX Laboratories (NASDAQ: IDXX) operating specialty research testing laboratories in the US and Germany, providing health monitoring, biologics/cell health, and preclinical testing services to more than 4,000 biopharma, CRO, academic, and government organizations worldwide.

Ownership category

akta.pro rank

Product category

Preclinical Laboratory Testing Services

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)

akta.pro secondary industries

Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA), Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA)

Keywords

• Preclinical laboratory testing
• Animal health monitoring
• Cell line authentication
• Biologics safety testing
• Research histopathology services

Headquarters

HQ city

Westbrook

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services: IDEXX BioAnalytics generates revenue through providing customized laboratory testing services to research organizations. Services include health monitoring, biologics and cell health testing, preclinical testing, and veterinary clinical trials. Clients order through the Client Portal or by contacting the support team for project-specific quotes.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

IDEXX BioAnalytics provides customized research testing solutions for the life sciences industry, delivering laboratory services across three core areas: Health Monitoring (sentinel and environmental pathogen screening for research animals), Biologics & Cell Health (cell line authentication, sterility, mycoplasma, and endotoxin testing), and Preclinical Testing (clinical pathology, histopathology, and bioanalysis). The company operates proprietary testing panels such as CellCheck™, IMPACT™, and h-IMPACT™, and serves over 4,000 organizations worldwide through its Client Portal and direct sales.

Product overview

IDEXX BioAnalytics provides customized research testing solutions as a comprehensive laboratory services portfolio, delivering fast and reliable results to over 4,000 organizations worldwide including biotechs, pharmaceutical companies, CROs, universities, research institutes, and government entities. The company's core offerings are organized into three main service areas: Health Monitoring (including sentinel health monitoring, environmental health monitoring via REPLACE EDT/SFSB and EDx panels, and species-specific panels for rodents and aquatics); Biologics & Cell Health (featuring CellCheck™ for cell line authentication, IMPACT™ and h-IMPACT™ panels for rodent and human pathogen testing, sterility testing, endotoxin testing, ConfirmPDX, and mycoplasma testing); and Preclinical Testing (comprising clinical pathology services such as hematology, chemistry, coagulation and inflammatory markers, histopathology with HALO Digital Image Analysis, core histology services including immunohistochemistry and whole slide scanning, and small molecule bioanalysis). Additional services include Real-Time PCR, serology, microbiology, veterinary clinical trials, custom projects, and ICS-Digital PSC testing. The company operates through the IDEXX BioAnalytics Client Portal for online ordering and submission.

Differentiator

Problem solved

Functional benefit

Products and services

• Health Monitoring

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Eurofins Scientific: Global testing services network covering pharma, biotech, and clinical diagnostics including sterility, endotoxin, mycoplasma, and cell-based testing. Comparable to IDEXX BioAnalytics in biologics/cell-health and sterility testing service lines.
• WuXi AppTec: Large CRO/CDMO offering preclinical, bioanalytical, and biologics testing services globally. Competes with IDEXX BioAnalytics in bioanalysis, preclinical testing, and biologics/cell health services.
• Labcorp (Labcorp Drug Development / CRL after acquisition): Major clinical and preclinical lab services provider with central lab, bioanalytical, and specialty testing capabilities. Overlaps with IDEXX BioAnalytics in central/specialty lab services for clinical trials and preclinical research.
• Charles River Laboratories: Global CRO with end-to-end preclinical and discovery services including research animal health monitoring, pathology, and bioanalysis. Directly competes with IDEXX BioAnalytics across preclinical testing, but at much larger scale and with broader service portfolio.
• Lonza Bioscience Solutions: CDMO and testing services provider with cell line authentication, mycoplasma, endotoxin, and sterility testing capabilities. Highly comparable to IDEXX BioAnalytics in biologics and cell health quality testing offerings.

Emerging players

• Bio-Techne: Provides reagents, assays, and testing services supporting cell and gene therapy, including sterility and mycoplasma testing reagents. Adjacent competitor in biologics/cell health testing products and services for research customers.
• Sartorius (CellGenix & BIA Separations): Provides cell and gene therapy manufacturing tools and testing solutions including mycoplasma/sterility testing components. Overlaps with IDEXX BioAnalytics' cell and gene therapy testing service lines.

Direct peers

• Inotiv: Preclinical CRO providing research models, pathology, and bioanalysis services. Competes directly with IDEXX BioAnalytics in preclinical testing, histopathology, clinical pathology, and animal model validation services.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDEXX BioAnalytics